NEW YORK, Jan. 17, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the Sequire Investor Summit. To learn more about the Sequire Investor Summit, please visit...
Hence then, the article about hoth therapeutics to attend sequire investor summit january 21 23 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025 )
Also on site :
- SEM Scanning Crosses the Global Guideline Threshold: Elevated to Recommended Pressure Injury Prevention Technology
- 50mph speed limits and double cost of second homes: What Burnham should do in first 100 days, according to Labour pressure group
- In HelloNation, Real Estate Expert Daniel K Whited Helps International Buyers Navigate U.S. Coastal Real Estate